Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 22, 2008
No genetic association between polymorphisms in the kainate-type glutamate receptor gene, GRIK4, and schizophrenia in the Chinese population
Zhiqiang Li, Zangdong He, Wei Tang, et al.
Schizophrenia Research
|
February 26, 2008
The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis
Gang Ma, ZangDong He, WenLi Fang, et al.
Journal of Psychiatric Research
|
March 21, 2007
No significant association between the genetic polymorphisms in the GSK-3 beta gene and schizophrenia in the Chinese population
Junwei Meng, Yongyong Shi, Xinzhi Zhao, et al.
Blood Cancer Journal
|
March 22, 2019
Antibody-drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study
Suzanne Trudel, Nikoletta Lendvai, Rakesh Popat, et al.
Journal of the Advanced Practitioner in Oncology
|
October 9, 2023
Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma
Rakesh Popat, Sagar Lonial, Peter M Voorhees, et al.
The Lancet. Oncology
|
November 17, 2018
Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial
Suzanne Trudel, Nikoletta Lendvai, Rakesh Popat, et al.
Human Molecular Genetics
|
April 21, 2011
A genome-wide association study reveals association between common variants in an intergenic region of 4q25 and high-grade myopia in the Chinese Han population
Zhiqiang Li, Jia Qu, Xun Xu, et al.
Gynecologic Oncology
|
November 12, 2024
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Matthew A Powell, David Cibula, David M O'Malley, et al.
Future Oncology (London, England)
|
July 11, 2024
A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, et al.
The New England Journal of Medicine
|
March 27, 2023
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 22, 2008
No genetic association between polymorphisms in the kainate-type glutamate receptor gene, GRIK4, and schizophrenia in the Chinese population
Zhiqiang Li, Zangdong He, Wei Tang, et al.
Schizophrenia Research
|
February 26, 2008
The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis
Gang Ma, ZangDong He, WenLi Fang, et al.
Journal of Psychiatric Research
|
March 21, 2007
No significant association between the genetic polymorphisms in the GSK-3 beta gene and schizophrenia in the Chinese population
Junwei Meng, Yongyong Shi, Xinzhi Zhao, et al.
Blood Cancer Journal
|
March 22, 2019
Antibody-drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study
Suzanne Trudel, Nikoletta Lendvai, Rakesh Popat, et al.
Journal of the Advanced Practitioner in Oncology
|
October 9, 2023
Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma
Rakesh Popat, Sagar Lonial, Peter M Voorhees, et al.
The Lancet. Oncology
|
November 17, 2018
Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial
Suzanne Trudel, Nikoletta Lendvai, Rakesh Popat, et al.
Human Molecular Genetics
|
April 21, 2011
A genome-wide association study reveals association between common variants in an intergenic region of 4q25 and high-grade myopia in the Chinese Han population
Zhiqiang Li, Jia Qu, Xun Xu, et al.
Gynecologic Oncology
|
November 12, 2024
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Matthew A Powell, David Cibula, David M O'Malley, et al.
Future Oncology (London, England)
|
July 11, 2024
A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, et al.
The New England Journal of Medicine
|
March 27, 2023
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, et al.
Page
of 2